Taiko Pharmaceutical Co's quarterly market cap
increased
from Jun. 2023 (円16,305 Mil) to Sep. 2023 (円17,465 Mil) but then
declined
from Sep. 2023 (円17,465 Mil) to Dec. 2023 (円15,135 Mil).
Taiko Pharmaceutical Co's annual market cap
declined
from Mar. 2020 (円66,802 Mil) to Dec. 2021 (円35,911 Mil) and
declined
from Dec. 2021 (円35,911 Mil) to Dec. 2022 (円17,169 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Taiko Pharmaceutical Co's Enterprise Value for Today is 円15,874 Mil.
Taiko Pharmaceutical Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Taiko Pharmaceutical Co's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Taiko Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiko Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Taiko Pharmaceutical Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Taiko Pharmaceutical Co's Market Cap falls into.
Taiko Pharmaceutical Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Taiko Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taiko Pharmaceutical Co (TSE:4574) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Taiko Pharmaceutical Co Market Cap Related Terms
Thank you for viewing the detailed overview of Taiko Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Taiko Pharmaceutical Co (TSE:4574) Business Description
Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4574 has been successfully added to your 